87 results
8-K
VIR
Vir Biotechnology Inc
4 Oct 22
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
8:23am
Authority Agreement (the “BARDA Agreement”) with the Biomedical Advanced Research and Development Authority (“BARDA”), part of the U.S. Department … circumstances, including for convenience. This program has been funded in whole or in part with federal funds from the Department of Health and Human Services
8-K
EX-99.1
VIR
Vir Biotechnology Inc
4 Oct 22
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
8:23am
, Inc. (Nasdaq: VIR) today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health … and industry to foster innovation and promote collaboration.
This program has been funded in whole or in part with federal funds from the Department of Health
8-K
VIR
Vir Biotechnology Inc
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
, Vir Biotechnology, Inc. (the “Company” or “Vir”) and the Biomedical Advanced Research and Development Authority (“BARDA”), part of the U.S. Department … been funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness
8-K
EX-99.1
gkpwt67 sz
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
tg0 486spvpin
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
8-K
EX-99.1
29yvi6
2 May 24
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:09pm
8-K
EX-99.1
14rl1rwe0d
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
8-K
EX-99.1
6yys apk2pxw
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
r7tpoq35
3 Nov 22
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
3bjr07jy
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
EX-99.1
n0g it61mr7
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
46kwptwcy6og69m6gh8
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
S-1
EX-10.43
g54ex3er
3 Sep 19
IPO registration
4:40pm
DRS
EX-10.43
r5mylave1zj8ebhl uwr
27 Jun 19
Draft registration statement
12:00am
S-1/A
EX-1.1
qxoba5tqto4wac
30 Sep 19
IPO registration (amended)
6:12am